Tag archive for ‘Launch of CAR-T products CTL-019 and Axi-Cel’
Key Investment Considerations Relating to Much Anticipated CAR-T Product Launches By Kite and Novartis Later This Year
Investment Conclusions: Cryoport: My recommended best way to invest in CAR-T launches (CYRX, Buy, $3.60) Kite Pharma: Seems priced for perfection (KITE, Underperform, $76.00) Novartis: Too big of a company to make an impact (NVS, No Opinion, $80.00) Be aware that June 14 could be a very important date. Novartis will present meaningful data on […]